Header Logo

Sheila Eswaran

Concepts (69)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Liver Transplantation
10
2022
96
2.090
Why?
Hepatitis, Alcoholic
6
2022
9
1.550
Why?
Chemical and Drug Induced Liver Injury
1
2021
7
0.730
Why?
Waiting Lists
3
2019
17
0.450
Why?
Chemoembolization, Therapeutic
1
2011
5
0.380
Why?
Alcohol Drinking
4
2020
80
0.370
Why?
Carcinoma, Hepatocellular
1
2011
27
0.370
Why?
Liver Neoplasms
1
2011
105
0.340
Why?
Liver Diseases, Alcoholic
2
2022
42
0.340
Why?
Liver Cirrhosis
3
2022
45
0.260
Why?
Alcohol Abstinence
3
2020
3
0.240
Why?
Biopsy
2
2021
220
0.210
Why?
Mastocytosis, Systemic
1
2022
6
0.210
Why?
Liver
2
2021
160
0.200
Why?
Humans
14
2022
28560
0.190
Why?
Middle Aged
8
2021
9316
0.190
Why?
Alcoholism
1
2022
74
0.190
Why?
Living Donors
1
2020
17
0.170
Why?
Female
10
2021
15818
0.170
Why?
Databases, Factual
2
2019
358
0.170
Why?
Consensus
1
2020
98
0.170
Why?
Liver Cirrhosis, Alcoholic
1
2019
5
0.160
Why?
Clinical Coding
1
2019
5
0.160
Why?
End Stage Liver Disease
1
2019
13
0.160
Why?
Time-to-Treatment
1
2019
35
0.160
Why?
Time Factors
4
2019
1501
0.150
Why?
Hemochromatosis
1
2017
1
0.150
Why?
Hemoglobinuria, Paroxysmal
1
2017
2
0.150
Why?
Nitriles
1
2017
14
0.140
Why?
Aromatase Inhibitors
1
2017
8
0.140
Why?
Hepatitis, Autoimmune
1
2017
5
0.140
Why?
Triazoles
1
2017
29
0.140
Why?
Models, Biological
1
2019
329
0.140
Why?
Antibodies, Monoclonal, Humanized
1
2017
94
0.140
Why?
Patient Selection
1
2018
207
0.130
Why?
Recurrence
3
2022
322
0.120
Why?
Adult
6
2019
8168
0.110
Why?
Cohort Studies
3
2019
1940
0.110
Why?
Treatment Outcome
4
2019
3620
0.100
Why?
Kidney Transplantation
1
2014
132
0.100
Why?
Breast Neoplasms
1
2017
409
0.100
Why?
Survival Analysis
3
2019
267
0.100
Why?
Kidney Failure, Chronic
1
2014
165
0.100
Why?
Retrospective Studies
5
2022
3612
0.100
Why?
Postoperative Complications
1
2019
934
0.100
Why?
Hepatitis C
1
2012
46
0.100
Why?
Ethiodized Oil
1
2011
1
0.090
Why?
Male
7
2019
15400
0.090
Why?
Survival Rate
1
2011
356
0.090
Why?
Aged
5
2017
9334
0.080
Why?
Risk Assessment
2
2019
677
0.060
Why?
Logistic Models
2
2019
396
0.060
Why?
Young Adult
1
2011
2102
0.060
Why?
Graft Survival
2
2014
102
0.050
Why?
Pyrroles
1
2022
24
0.050
Why?
United States
2
2019
2197
0.050
Why?
Pyrazoles
1
2022
58
0.050
Why?
Artificial Intelligence
1
2022
35
0.050
Why?
Life Expectancy
1
2019
28
0.040
Why?
Medical Records
1
2019
34
0.040
Why?
Diagnostic Errors
1
2019
31
0.040
Why?
Neoplasm Staging
1
2017
371
0.030
Why?
Age Factors
1
2018
788
0.030
Why?
Incidence
1
2018
774
0.030
Why?
Severity of Illness Index
1
2019
990
0.030
Why?
Prospective Studies
1
2019
1807
0.030
Why?
Follow-Up Studies
1
2018
1863
0.030
Why?
Risk Factors
1
2018
2412
0.020
Why?
Disease Progression
1
2012
722
0.020
Why?
Eswaran's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (69)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_